ResMed beats earnings forecast as revenue jumps ten per cent to $1.3 billion

ResMed has beaten its earnings forecast in the second quarter despite concerns from investors around weight loss drugs impacting the necessity for sleep device products.
ResMed’s revenue jumped ten per cent to $1.3 billion.
The figures came as profit margins expanded and the company saw higher sales of its sleep products and masks.